Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07150858

Erythropoietin - Albumin Platelet-rich Fibrin in Transcrestal Sinus Lifting With Simultaneous Implant Placement

Comparison Between Erythropoietin-enhanced Albumin Platelet-rich Fibrin and Albumin Platelet-rich Fibrin in Transcrestal Sinus Lifting With Simultaneous Implant Placement

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Alexandria University · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Background: Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence trans crestal sinus lifting with albumin platelet rich plasma. Aim of the study: To compare between erythropoietin and albumin platelet rich fibrin transcrestal sinus lifting versus albumin platelet rich fibrin transcrestal sinus lifting using piezoelectric device in patients with atrophic maxilla. Methods: This study will be carried out as a randomized

Conditions

Interventions

TypeNameDescription
OTHERErythropoietin and albumin PRF gel + implant placementThis group will be treated by transcrestal sinus lifting with erythropoietin and albumin PRF gel with simultaneous implant placement.
OTHERAlbumin PRF gel +implant placementThis group (the Control group) will be treated with transcrestal sinus lifting using albumin PRF gel, with simultaneous implant placement.

Timeline

Start date
2025-05-25
Primary completion
2026-07-25
Completion
2026-07-25
First posted
2025-09-02
Last updated
2025-09-02

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07150858. Inclusion in this directory is not an endorsement.